黑料网

Internal mammary artery; Autologous breast reconstruction; Medial mastectomy; Recipient vascular; Indocyanine green

Introduction

Their position and have an effect on have no longer been explored but after the DIEP flap. Traditional donor web sites for autologous breast reconstruction encompass the abdomen, thigh, buttock, and posterior thorax. The authors describe the use of the reverse lateral intercostal perforator flap originating from the sub mammary area as a choice alternative for breast reconstruction. The inferior gluteal artery perforator flap is a choice method for autologous breast reconstruction. In distinction to different typically used techniques, there is a paucity of literature on the protection and efficacy of the IGAP flap. The goal of this learn about was once to operate a systematic literature assessment and meta-analysis of postoperative results and problems related with the IGAP in autologous breast reconstructions to validate its safety. Patient’s present process autologous breast reconstruction generally requires in addition operations as phase of their reconstructive journey. This includes contralateral breast symmetrisation and nipple-areola complicated reconstruction. Restrained get right of entry to noncompulsory working house led us to put in force a one-stop breast reconstruction pathway. Recent traits have proven that ABR looks to be increasing. Indications for the usage of abdominal-based flaps for breast reconstruction regularly consist of affected person preference, extreme tender tissue harm secondary to radiation therapy, and even failed implant reconstruction. Contraindications are few however encompass preceding abdominoplasty or any process that has disrupted the inferior Epigastric vascular grant to the belly wall. Several elements and affected person traits ought to be viewed at some stage in the preliminary dialogue of and comparison for autologous breast reconstruction which include oncologic cure plan, scientific comorbidities, contemporary breast volume/contour, physique habitus, reconstructive goals, and affected person preference. Breast reconstructions that use autologous belly tissue end result in breasts with an herbal structure and consistency. One of the essential issues is belly bulging. Because the stomach wall anxiety increased, excessive visceral quantity may want to make bigger the prevalence fee of belly bulging. We used an easy method bought via CT imaging to examine this relationship in sufferer’s present process and belly free flap for unilateral breast reconstruction [1-5].

Discussion

The use of the internal mammary artery (IMA) as a recipient vessel in autologous breast reconstruction surgery has been a subject of interest and ongoing research. Indocyanine green (ICG) is a nearinfrared fluorescent dye that can be used to assess tissue perfusion intraoperatively. It provides real-time visualization of blood flow and can help evaluate the viability of tissue flaps. Observational studies have investigated the effect of employing the IMA as a recipient vessel on medial mastectomy skin flap perfusion using ICG. These studies aim to determine whether using the IMA improves blood flow to the reconstructed breast and reduces the risk of complications such as flap necrosis. One potential advantage of using the IMA as a recipient vessel is its proximity to the breast area, allowing for better blood supply to the reconstructed tissue. The IMA is known for its robust blood flow and is commonly used as a recipient vessel in coronary artery bypass grafting due to its excellent long-term patency rates. By utilizing the IMA in breast reconstruction, surgeons hope to achieve similar benefits. Observational studies using ICG have shown promising results regarding the use of the IMA as a recipient vessel. These studies have reported improved perfusion in the medial mastectomy skin flap when the IMA was utilized. The visualization provided by ICG allows surgeons to assess blood flow and make necessary adjustments during surgery to optimize flap viability. However, it is important to note that observational studies have limitations and cannot establish a cause-andeffect relationship. Randomized controlled trials (RCTs) would provide stronger evidence to support the findings from observational research. RCTs could compare outcomes between cases where the IMA was used as the recipient vessel and cases where other vessels were employed. In conclusion, observational research using ICG has suggested that employing the internal mammary artery as a recipient vessel in autologous breast reconstruction may improve medial mastectomy skin flap perfusion. However, further research, particularly RCTs, is needed to confirm these findings and establish the benefits and potential risks associated with this surgical approach [6-11].

Conclusion

In conclusion, observational research using indocyanine green (ICG) has shown promising results regarding the use of the internal mammary artery (IMA) as a recipient vessel in autologous breast reconstruction. These studies have indicated improved perfusion in the medial mastectomy skin flap when the IMA was employed. However, it is important to note that observational research has limitations, and further evidence from randomized controlled trials (RCTs) is needed to confirm these findings. RCTs would provide more robust evidence to support the benefits and potential risks associated with using the IMA as a recipient vessel. Therefore, while the initial results are encouraging, more research is required before definitive conclusions can be drawn regarding the effect of employing the IMA on medial mastectomy skin flap perfusion in autologous breast reconstruction.

Acknowledgment

None

Conflict of Interest

None

1. Ouyang S, Zhou X, Chen Z (2019) Cancer Cell Int 19:72.

, ,

2. Sharmila AP, Gauravi AM (2019) . Minerva Ginecol 71: 313-320.

, ,

3. Chen H.Z., Tsai S.Y., Leone G (2009) Cancer 9:785–797.

, ,

4. Cabral H, Kinoh H, Kataoka K (2020) . Acc Chem Res 53: 2765-2776.

, ,

5. Brunt AM, Haviland JS, Wheatley DA, Sydenham MA, Alhasso A, et al. (2020) . Lancet 395: 1613-1626.

, ,

6. Mamounas EP, Bandos H, Lembersky BC, Jeong JH, Geyer Jr CE, et al. (2019) . Lancet Oncol 20: 88-99.

, ,

7. Grassi ES, Ghiandai V, Persani L (2021) . J Clin Med 10: 1455.

, ,

8. Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, et al. (2017) . JAMA 318: 918-926.

, ,

9. Koulis TA, Phan T, Olivotto IA (2015) . Breast Cancer (Dove Med Press) 7: 363-370.

, ,

10. Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, et al. (2017) . JAMA 318: 918-926.

, ,

11. Koulis TA, Phan T, Olivotto IA (2015) . Breast Cancer (Dove Med Press) 7: 363-370.

, ,